铁:瘤免疫疗法的新视角
Yuan Xu1, Mingpai Ge1, Yuqing Xu1
1Changhai Hospital, Second Military Medical University, Shanghai, China.
Frontiers in immunology
|April 22, 2025
概括
细胞死亡过程铁亡,通过影响瘤细胞和免疫细胞,影响癌症免疫力. 向铁亡可能会提高癌症免疫治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 铁亡是一种编程细胞死亡的新型形式.
- 它的特点是依赖于铁的活性氧物种 (ROS) 和脂质过氧化物的积累.
- 铁化与铁和脂质代谢密切相关,这些代谢对免疫细胞功能也至关重要.
研究的目的:
- 确定免疫细胞中的铁灭信号通路和代谢过程.
- 为了总结铁死在瘤透免疫细胞中的作用.
- 为了探索铁化在癌症免疫治疗中的潜力.
主要方法:
- 审查现有的关于铁,铁代谢,脂质代谢和癌症免疫学的文献.
- 分析瘤微环境中的铁和免疫细胞之间的相互作用.
- 综合目前对铁灭诱导剂及其对免疫疗法的影响的理解.
主要成果:
- 铁化增强瘤细胞的免疫性,并与免疫细胞相互作用.
- 铁灭诱导剂可以通过调节瘤免疫微环境来提高免疫疗法的有效性.
- 铁亡在瘤透免疫细胞的功能中起着重要作用.
结论:
- 铁化具有巨大的潜力,作为癌症免疫治疗中的新型治疗点.
- 预计在免疫疗法中进一步阐明铁死机制.
- 预计在临床瘤学中将与免疫疗法结合向铁亡的治疗应用.
相关概念视频
Tumor Immunotherapy
398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


